1. Marchesini, Matteo, Gherli, Andrea, Simoncini, Elisa, Colla, Simona, Roti, Giovanni. 2024. Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML. In Nature communications, 15, 4739. doi:10.1038/s41467-024-48953-3. https://pubmed.ncbi.nlm.nih.gov/38834613/
2. Kumar, Shashank, Shuaib, Mohd, AlAsmari, Abdullah F, Alqahtani, Faleh, Gupta, Sanjay. 2023. GNL3 and PA2G4 as Prognostic Biomarkers in Prostate Cancer. In Cancers, 15, . doi:10.3390/cancers15102723. https://pubmed.ncbi.nlm.nih.gov/37345060/
3. Massignam, Eloísa Toscan, Dieter, Cristine, Assmann, Taís Silveira, Canani, Luis Henrique, Crispim, Daisy. 2022. The rs705708 A allele of the ERBB3 gene is associated with lower prevalence of diabetic retinopathy and arterial hypertension and with improved renal function in type 1 diabetic patients. In Microvascular research, 143, 104378. doi:10.1016/j.mvr.2022.104378. https://pubmed.ncbi.nlm.nih.gov/35594935/
4. Koach, Jessica, Holien, Jessica K, Massudi, Hassina, Cheung, Belamy B, Marshall, Glenn M. 2019. Drugging MYCN Oncogenic Signaling through the MYCN-PA2G4 Binding Interface. In Cancer research, 79, 5652-5667. doi:10.1158/0008-5472.CAN-19-1112. https://pubmed.ncbi.nlm.nih.gov/31501192/
5. Alan Harris, R, Archer, Kellie J, Goodarzi, Mark O, McAllister, Jan M, Strauss, Jerome F. 2022. Loci on chromosome 12q13.2 encompassing ERBB3, PA2G4 and RAB5B are associated with polycystic ovary syndrome. In Gene, 852, 147062. doi:10.1016/j.gene.2022.147062. https://pubmed.ncbi.nlm.nih.gov/36423778/
智鼠故事 
